Navigation Links
AGA Institute and Horizon Therapeutics Launch 'Connect to Protect' Program to Educate Physicians and Consumers on Risks Associated With NSAID Use
Date:6/1/2009

- Webinar on June 9 to discuss the prevalence and prevention of NSAID-induced ulcers available at www.connecttoprotect.com -

BETHESDA, Md. and CHICAGO, June 1 /PRNewswire/ -- The American Gastroenterological Association (AGA) Institute and Horizon Therapeutics, Inc. today launched Connect to Protect, a program to increase awareness about the gastrointestinal (GI) risks associated with the use of non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen and naproxen. Connect to Protect was created to highlight the connection between NSAID use and GI risks, and to encourage patients and physicians to connect more often about ways to avoid NSAID-induced ulcers, including but not limited to GI protective co-therapy.

"NSAIDs are among the most widely prescribed classes of drugs in the world, yet there is still very limited discussion among healthcare providers and their patients about the impact long-term use could have," said Byron Cryer, MD, professor, Internal Medicine - Digestive and Liver Diseases, University of Texas Southwestern, and independent medical advisor, Connect to Protect program. "The goal of Connect to Protect is to facilitate the discussion between physicians and patients around the potential risks in taking chronic NSAIDs and to understand how to reduce a patient's risk."

Connect to Protect will sponsor an educational Webinar hosted by Dr. Cryer on Tuesday, June 9, 2009 from 12 p.m. to 1 p.m. EDT, during which he will discuss the prevalence of NSAID-induced ulcers, the causes and ways to reduce the risk. The Webinar is open to healthcare providers and media. To register in advance, please visit: www.connecttoprotect.com.

"We are excited to partner with the AGA Institute
'/>"/>

SOURCE Horizon Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Codexis Licenses New Drug Metabolite Profiling and Lead Diversification Technology From the California Institute of Technology
2. Southern Research Institute Licenses Anti-Cancer Drug Compound to Virium Pharmaceuticals
3. Midwest Research Institute Launches Center for Biological Safety and Security (CBS2)
4. New Scientists Boost Disease-based Research at Boston Biomedical Research Institute
5. Solazyme Selected for National Institute of Standards and Technology Award
6. HUYA Bioscience International Licenses Clinical Stage Anti-Arrhythmic Compound from the Shanghai Institute of Materia Medica
7. Caliper Life Sciences Awarded National Institute of Environmental Health Services Contract Valued to $7.0 Million
8. National Institutes of Health Awards $25.5M Contract to SRA
9. The USC Stevens Institute for Innovation Opens Shop on US Health Sciences Campus
10. Infectious Disease Research Institute Receives Grant for Acquisition of Core Research Equipment from M.J. Murdock Charitable Trust
11. The USC Stevens Institute for Innovation Opens Shop on USC Health Sciences Campus

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...wswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI)...inth Circuit Court of Appeals reversed a U.S. Dist...wed to pursue all of its claims against The Lash G...for trial. CTI filed a complaint against The Lash...sultant for CTI,s product TRISENOX, in 2007 seekin...
(Date:11/19/2009)...wire/ -- Danish Prince Joachim inaugurated the DON...alundborg, Denmark, on Wednesday, November 18. The...2nd generation ethanol demonstration biorefineries...lant,s innovative process for converting straw to ...st to market with commercial enzymes for convertin...
(Date:11/19/2009)...ire-FirstCall/ -- NeoStem, Inc. (NYSE Amex: NBS )...etter to its shareholders, discussing the Company,...armaceuticals Holdings, Inc. (CHBP), an integrated...Republic of China. The merger gives NeoStem a cont... Co. Ltd., CHBP,s primary operating subsidiary and...
(Date:11/19/2009)...ire/ - Aegera Therapeutics Inc. announced today th...e 2B study of AEG35156, a targeted antisense thera...ogy indications. ,, The study, entitled "An Ope...nhibitor of Apoptosis (XIAP) Antisense AEG35156 Gi...darubicin in AML Following Failure of a Single Sta...
Breaking Biology Technology:Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2
... Blood America, Inc. (OTC Bulletin Board: CBAI), t...pany ( http://www.cordblood-america.com ) focused ...s to families nationwide and internationally, toda...tunity Fund to restructure its current outstanding...ward for Cord Blood America. With the signing of ...
...s to produce methyl ethyl ketone from renewable fe.... 25 Researchers at Genomatica, Inc., a sustainab...uring process for methyl ethyl ketone (MEK), a com... valued at more than $2 billion. The rapid develo...technology can repeatedly target specific chemical...
...Therapeutics, Inc. (NYSE Alternext US: SYI) today...h the current holders of its Series B Preferred St...,000 in accrued dividend obligations relating to t...8 has been converted into senior secured promissor.... Interest at the rate of 1.25% per year shall be...
Other Biology Technology:Cord Blood America Restructures Debt; Projects to be Cash Flow Positive 2New Genomatica Chemical Process Targets Ailing Ethanol Assets 2New Genomatica Chemical Process Targets Ailing Ethanol Assets 3New Genomatica Chemical Process Targets Ailing Ethanol Assets 4New Genomatica Chemical Process Targets Ailing Ethanol Assets 5Synvista Therapeutics Announces Restructuring of Dividend Obligation to Preferred Stockholders and Decision to Delist from NYSE Alternext and Terminate SEC Registration of Common Stock 2Synvista Therapeutics Announces Restructuring of Dividend Obligation to Preferred Stockholders and Decision to Delist from NYSE Alternext and Terminate SEC Registration of Common Stock 3Synvista Therapeutics Announces Restructuring of Dividend Obligation to Preferred Stockholders and Decision to Delist from NYSE Alternext and Terminate SEC Registration of Common Stock 4
(Date:11/19/2009)... WALL, N.J., Nov. 19 BIO...), a leader in wireless public safety and finger-b... that the Special Shareholder Meeting held today w...e a quorum was not present. ,, (Logo: http://w..., While an impressive 99.3% of the 35 million v...
(Date:11/19/2009)...y Penn State,s Ross Hardison, T. Ming Chu Professo... a large step toward unraveling how regulatory pro...ng development and growth. Working with collaborat...at Children,s Hospital of Philadelphia, they focus...g red blood cells (erythrocytes). These cells cont...
(Date:11/19/2009)...er, University of Cincinnati professor of paleonto...nd co-author Michael Foote of the University of Ch...of Science with their paper, "Epicontinental Sea... Extinction and Origination." , For many years, ...ory of biodiversity have focused on charting the m...
Breaking Biology News(10 mins):BIO-key(R) Provides Update to Special Shareholder Meeting 2BIO-key(R) Provides Update to Special Shareholder Meeting 3New research into the mechanisms of gene regulation 2New research into the mechanisms of gene regulation 3New research into the mechanisms of gene regulation 4New research into the mechanisms of gene regulation 5Paleontologists find extinction rates higher in open-ocean settings during mass extinctions 2Paleontologists find extinction rates higher in open-ocean settings during mass extinctions 3Paleontologists find extinction rates higher in open-ocean settings during mass extinctions 4Brown professor continues debate over recovered memory 50995 1Brown professor continues debate over recovered memory 50995 2Providence Service Corporation Does Not Expect California Budget Issues to Materially Impact Its Business in the State 50992 1Providence Service Corporation Does Not Expect California Budget Issues to Materially Impact Its Business in the State 50992 2Fewer Shots Could Still Protect Kids From Pneumonia 50989 1Fewer Shots Could Still Protect Kids From Pneumonia 50989 2
...search Associate at the Stowers Institute for Medi... Institute Investigator and an investigator with t...ted that the long-studied family of transcription ...ion during the formation of the vertebral precurso... which were published in the March 7 issue of Deve...
...ultures and in most mammals, males are usually mor... simple to blame male hormones, like testosterone,...t,s in our genes, too. , Indeed such social behavi...arch on mice by neuroscientists at the University ...x chromosomes, XX versus XY, are also responsible ...
...al trade in the Roti Island snake-necked turtle, f...all but extinct in the wild. Exotic pet enthusias...ing the illegal trade for the turtle, often withou...se. No legal trade of this species has been allow...life trade monitoring network of WWF and IUCN, "Tr...
Other Biology News:Stowers scientists demonstrate mechanism of vertebral formation 2Sex chromosome genes influence aggression andmaternal behavior, say UVa researchers 2Illegal trade is propelling rare turtle toward extinction, new report 2
Goat Anti-ORC2L Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-Human B3GALT2 Polyclonal Antibody, Unconjugated from ABR-Affinity BioReagents
Mouse Anti-Human XPC Polyclonal Antibody, Unconjugated from ABR-Affinity BioReagents
Film Exposure Folders from Upstate
Biology Products: